治疗相关中枢性睡眠呼吸暂停:生理机制与临床实践
该综述描述了对治疗相关中枢性睡眠呼吸暂停(TECSA)患者的管理方法。TECSA在OSA滴定研究中发生率约8%,与人口学、临床、多导睡眠图及滴定研究相关因素有关,其病理生理机制与中枢性和阻塞性睡眠呼吸暂停相互交织。TECSA是动态过程,多数患者持续气道正压治疗可自行缓解,管理策略旨在消除异常呼吸事件、稳定睡眠结构并改善基础合并症,CPAP仍为标准治疗,部分患者可早期换用替代正压通气模式。
要点
- TECSA在OSA滴定研究中发生率约8%,与多种因素相关。
- TECSA多为暂时性,持续CPAP治疗下多数可自行缓解。
- 管理目标包括消除异常呼吸事件、稳定睡眠结构和改善合并症。
核心结论
- TECSA是一个动态过程,多数患者持续正压通气治疗可自行缓解,部分持续存在,少数新发。
- CPAP仍是TECSA的标准治疗,期望管理适用于多数短暂病例,部分患者可早期换用替代正压通气模式。
研究设计与样本
- 综述,旨在描述TECSA患者的管理方法,未报告系统检索范围。
主要发现
- TECSA在OSA滴定研究中发生率约为8%。
- TECSA与人口学、临床、多导睡眠图及滴定研究相关因素有关。
- TECSA与中枢性睡眠呼吸暂停共享相似病理生理机制,通气不稳定和上气道狭窄在两者中均存在。
临床怎么用
- 管理策略旨在消除异常呼吸事件、稳定睡眠结构并改善基础合并症。
- 鉴于多数病例短暂,期望管理是合适的;部分患者可早期换用替代正压通气模式。
- 其他治疗选项包括补充氧气和药物治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this review was to describe our management approach to patients with treatment-emergent central sleep apnea (TECSA). The emergence of central sleep apnea during positive airway pressure therapy occurs in approximately 8% of titration studies for OSA, and it has been associated with several demographic, clinical, and polysomnographic factors, as well as factors related to the titration study itself. TECSA shares similar pathophysiology with central sleep apnea. In fact, central and OSA pathophysiologic mechanisms are inextricably intertwined, with ventilatory instability and upper airway narrowing occurring in both entities. TECSA is a "dynamic" process, with spontaneous resolution with ongoing positive airway pressure therapy in most patients, persistence in some, or appearing de novo in a minority of patients. Management strategy for TECSA aims to eliminate abnormal respiratory events, stabilize sleep architecture, and improve the underlying contributing medical comorbidities. CPAP therapy remains a standard therapy for TECSA. Expectant management is appropriate given its transient nature in most cases, whereas select patients would benefit from an early switch to an alternative positive airway pressure modality. Other treatment options include supplemental oxygen and pharmacologic therapy.
引用
- Zeineddine S, Badr MS. Treatment-Emergent Central Apnea: Physiologic Mechanisms Informing Clinical Practice. Chest. 2021. PMID: 33497650. doi:10.1016/j.chest.2021.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。